Table 3.

Non-invasive fibrosis scores and incident CVD.

Covariate	Univariable SHR (95% CI)	p-value
NFS	1.55 (1.32–1.83)	0.01
>0.676	4.61 (2.28–9.32)	0.01
<−1.455	0.18 (0.07–0.43)	0.01
FIB-4	1.33 (1.20–1.48)	0.01
>2.67	2.63 (1.23–5.64)	0.01
<1.3	0.42 (0.21–0.85)	0.02
APRI	1.57 (0.95–2.59)	0.08
>0.7	1.31 (0.59–2.90)	0.51
AST/ALT ratio	3.15 (1.85–5.39)	0.01
MELD-Na	1.09 (1.02–1.16)	0.01

Abbreviations: APRI, AST to platelet ratio index; AST, aspartate aminotransferase; CI, confidence interval; CVD, cardiovascular disease; FIB-4, fibrosis-4 index; MELD-Na, Model for End-Stage Liver Disease incorporating sodium; NFS, NAFLD fibrosis score; SHR, subhazard ratio.